Araştırma Makalesi

Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region

Cilt: 14 Sayı: 2 27 Haziran 2025
PDF İndir
EN TR

Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region

Öz

Human Immunodeficiency Virus (HIV) positive patients are exposed to radiation therapy for the treatment of various types of cancer. During these treatments, it is inevitable that radiation will interact with the antiviral drugs used. Determining the radiation attenuation parameters of drugs used in HIV treatment is therefore considered essential. In this context, the radiation attenuation capabilities of the HIV drugs were analyzed based on the parameters mass attenuation coefficient (MAC), atomic cross section (ACS), electronic cross section (ECS), effective atomic number (Zeff), exposure build-up factor (EBF) and energy absorption build-up factor (EABF). The values were investigated in the 0.015-15 MeV range using the Phy-X/PSD software. The build-up factors were also analyzed using the geometric progression (G-P) method up to a penetration depth of 40 mean free path (MFP). Based on the results, Efavirenz and Indinavir were found to have the highest and lowest radiation reduction capacities, respectively. It is believed that these findings can be used to make medical processes more beneficial.

Anahtar Kelimeler

Destekleyen Kurum

No financial support has been received from any organization or person to prepare this manuscript.

Etik Beyan

1. The authors declare that there is no conflict of interest or competing interest relevant to the content of this manuscript. 2. All national and international ethical guidelines have been adhered to in the preparation of the article.

Kaynakça

  1. Au, N. P. B., Wu, T., Kumar, G., Jin, Y., Li, Y. Y. T., Chan, S. L., ... & Ma, C. H. E. (2024). Low-dose ionizing radiation promotes motor recovery and brain rewiring by resolving inflammatory responses after brain injury and stroke. Brain, Behavior, and Immunity, 115, 43-63.
  2. Evans, E., & Stafford, J. (2018). Principles of cancer treatment by radiotherapy. Surgery (Oxford), 36(3), 111-116.
  3. Cuttler, J. M. (2020). Application of low doses of ionizing radiation in medical therapies. Dose-response, 18(1), 1559325819895739.
  4. Chirenje, Z. M. (2005). HIV and cancer of the cervix. Best practice & research Clinical obstetrics & gynaecology, 19(2), 269-276.
  5. Shiels, M. S., Pfeiffer, R. M., Gail, M. H., Hall, H. I., Li, J., Chaturvedi, A. K., ... & Engels, E. A. (2011). Cancer burden in the HIV-infected population in the United States. Journal of the National Cancer Institute, 103(9), 753-762.
  6. Akman, F., & Kaçal, M. R. (2018). Investigation of radiation attenuation parameters of some drugs used in Chemotherapy in the Wide Energy Region. Journal of Radiology and Oncology, 2, 047-052.
  7. Çağlar, İ., & Cengiz, G. B. (2021). Evaluation of radiation attenuation properties of some cancer drugs. Adıyaman University Journal of Science, 11(2), 503-522.
  8. Tuğrul, T. (2020). Investigation of mass attenuation coefficients, effective atomic numbers, and effective electron density for some molecules: study on chemotherapy drugs. Journal of Radiation Research and Applied Sciences, 13(1), 758-764.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Atom ve Molekül Fiziği, Nükleer Fizik, Radyofizik, Parçacık ve Yüksek Enerji Fiziği (Diğer)

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

27 Haziran 2025

Gönderilme Tarihi

7 Ocak 2025

Kabul Tarihi

24 Mayıs 2025

Yayımlandığı Sayı

Yıl 2025 Cilt: 14 Sayı: 2

Kaynak Göster

APA
Akbaba, U., Kamacı, K., & Şakar, E. (2025). Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. Turkish Journal of Nature and Science, 14(2), 204-212. https://doi.org/10.46810/tdfd.1614991
AMA
1.Akbaba U, Kamacı K, Şakar E. Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. TDFD. 2025;14(2):204-212. doi:10.46810/tdfd.1614991
Chicago
Akbaba, Ugur, Kübra Kamacı, ve Erdem Şakar. 2025. “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”. Turkish Journal of Nature and Science 14 (2): 204-12. https://doi.org/10.46810/tdfd.1614991.
EndNote
Akbaba U, Kamacı K, Şakar E (01 Haziran 2025) Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. Turkish Journal of Nature and Science 14 2 204–212.
IEEE
[1]U. Akbaba, K. Kamacı, ve E. Şakar, “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”, TDFD, c. 14, sy 2, ss. 204–212, Haz. 2025, doi: 10.46810/tdfd.1614991.
ISNAD
Akbaba, Ugur - Kamacı, Kübra - Şakar, Erdem. “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”. Turkish Journal of Nature and Science 14/2 (01 Haziran 2025): 204-212. https://doi.org/10.46810/tdfd.1614991.
JAMA
1.Akbaba U, Kamacı K, Şakar E. Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. TDFD. 2025;14:204–212.
MLA
Akbaba, Ugur, vd. “Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region”. Turkish Journal of Nature and Science, c. 14, sy 2, Haziran 2025, ss. 204-12, doi:10.46810/tdfd.1614991.
Vancouver
1.Ugur Akbaba, Kübra Kamacı, Erdem Şakar. Investigation of Radiation Interaction Parameters of Anti-Human Immunodeficiency Virus Drugs in Wide Energy Region. TDFD. 01 Haziran 2025;14(2):204-12. doi:10.46810/tdfd.1614991